Evolysse Form and Smooth Injectable HA Gels Hit Market
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.